STOCKHOLDERS’ EQUITY (Tables)

9 Months Ended

Jul. 31, 2024

The table below presents option activity for the nine months ended July 31, 2024:

SCHEDULE OF OPTION ACTiVITY

	Number of Shares		Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Life (in years)		Aggregate intrinsic value

Balance at October 31, 2023		1,112,923		10.84		6.64		16,889,060
Options exercised		-		-		-		-
Options granted		-		-		-		-
Options expired		-		-		-		-
Options forfeited		-		-		-		-
Balance at July 31, 2024		1,112,923	$	10.84		5.89	$	1,560,431

A summary of the Company’s common stock underlying the outstanding warrants as of July 31, 2024, is as follows:

	Underlying Number of Shares			Average Exercise Price		Weighted Average Life

Outstanding at October 31, 2023		444,454			20.56		1.65
Warrants A – Granted during the period		-			-		-
Warrants B – Granted during the period		-			-		-
Warrants A – Expired during the period		(113,846	)		13.00		-
Warrants B – Expired during the period		-			-		-
Outstanding at July 31, 2024		330,608		$	23.29		1.26

Vitro Biopharma, Inc. 10-Q